IL6 and breast cancer: To confirm that Faecalibacterium prausnitzii inhibited the growth of breast cancer cell line MCF-7 through IL-6, recombinant human IL-6 was used to exogenously disrupt the effect of Faecalibacterium prausnitzii for IL-6 (Fig. 9).